Thu, February 8, 2024
Wed, February 7, 2024
Tue, February 6, 2024

Jason Butler Reiterated (ACAD) at Buy and Held Target at $42 on, Feb 7th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-42-on-feb-7th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Butler of JMP Securities, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy and Held Target at $42 on, Feb 7th, 2024.

Jason has made no other calls on ACAD in the last 4 months.



There are 13 other peers that have a rating on ACAD. Out of the 13 peers that are also analyzing ACAD, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Reiterated at Hold and Held Target at $25 on, Monday, February 5th, 2024
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $27 on, Monday, December 18th, 2023
  • Neena Bitritto-Garg of "Deutsche Bank" Downgraded from Strong Buy to Hold and Held Target at $25 on, Thursday, December 14th, 2023


These are the ratings of the 10 analyists that currently disagree with Jason


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $42 on, Friday, February 2nd, 2024
  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $40 on, Tuesday, January 30th, 2024
  • Joseph Stringer of "Needham" Upgraded from Hold to Strong Buy and Held Target at $37 on, Wednesday, January 24th, 2024
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $40 on, Friday, December 29th, 2023
  • Jeffrey Hung of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $40 on, Tuesday, December 19th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $38 on, Wednesday, December 13th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, November 6th, 2023
  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $33 on, Friday, November 3rd, 2023
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $33 on, Tuesday, October 17th, 2023
  • Tessa Romero of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $32 on, Tuesday, October 10th, 2023

Publication Contributing Sources